So here’s a classic market puzzle: a company reports earnings that beat expectations, raises its full-year outlook, and announces a bigger dividend and buybacks. Its stock, naturally, drops 3.4% in premarket trading. Welcome to the world of ASML Holding N.V. (ASML), the Dutch firm that is the world’s sole supplier of the extreme ultraviolet (EUV) lithography machines needed to make the most advanced chips.
The chip equipment maker reported first-quarter 2026 results on Wednesday. Net sales came in at 8.77 billion euros ($10.26 billion), up from 7.74 billion euros a year earlier and slightly above analyst estimates of $10.21 billion. GAAP earnings were 7.15 euros per share ($8.37), also ahead of the consensus estimate of $7.72. So far, so good. The gross margin did dip 100 basis points year-over-year to 53.0%, and the company ended the quarter with 8.38 billion euros in cash.
On the capital return front, ASML said it plans to declare a total dividend of 7.50 euros per ordinary share for 2025, which is a 17% increase from 2024. It also repurchased about 1.1 billion euros worth of its own shares during the quarter. Again, typically shareholder-friendly stuff.
The narrative from management was overwhelmingly positive on demand. CEO Christophe Fouquet said semiconductor demand continues to outpace supply, "driven by sustained investment in AI infrastructure." He noted customers are accelerating their capacity expansion plans for 2026 and beyond. CFO Roger Dassen added that ASML expects to produce at least 60 of its crucial EUV Low-NA systems this year and potentially 80 units in 2027, as growing AI demand pushes customers to ramp up advanced manufacturing nodes like 2-nanometer technology.
But then we get to the part that might explain the stock’s slide: geopolitics. Dassen emphasized that while 2026 is shaping up to be "a very strong year," the company has built flexibility into its guidance to "accommodate potential outcomes of the export control discussions." In other words, ASML is saying it can handle whatever new rules come its way, but it’s still a variable that investors have to price in. The overall tone was confident—bullish on demand, cautious but prepared on restrictions.
Perhaps adding to the caution was the outlook. For the second quarter, ASML expects net sales of 8.4 billion euros to 9.0 billion euros, which is below the analyst consensus of 9.1 billion euros. The gross margin is forecast between 51% and 52%. For the full year, however, the company raised its net sales outlook to a range of 36 billion euros to 40 billion euros, up from a prior range of 34 billion euros to 39 billion euros. The forecast compares with analyst expectations of 37.9 billion euros. The full-year gross margin is expected to be 51% to 53%.
So, to sum it up: strong quarter, raised annual guidance, big dividend hike, and a management team talking up an AI-fueled boom. Yet the stock drops. It seems the market is still chewing over that slightly soft Q2 guide and the ever-present "what if" of export controls, even as ASML insists it can accommodate them. Sometimes, even when you check all the boxes, Wall Street wants a little more reassurance.
